AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Alligator Bioscience

Declaration of Voting Results & Voting Rights Announcements Jan 31, 2025

3138_rns_2025-01-31_f01c372f-a327-4334-a962-4d5f9212beb6.pdf

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

CHANGE IN NUMBER OF SHARES AND VOTES IN ALLIGATOR BIOSCIENCE

During the month of January, the number of shares and votes in Alligator Bioscience AB has changed as a result of the exercise of warrants series TO 9 that were issued in connection with the rights issue of units resolved by the Board of Directors on 8 February 2024 and approved by the Extraordinary General Meeting held on 14 March 2024.

As of 31 January 2025, the number of shares in Alligator Bioscience AB amounts to 760,487,243 shares, of which 759,708,074 are ordinary shares with one vote each and 779,169 are series C shares with 1/10 vote each. The total number of votes in the company amounts to 759,785,990.9.

For further information, please contact:

Søren Bregenholt, CEO E-mail: [email protected] Phone: +46 (0) 46 540 82 00

This information is information that Alligator Bioscience is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2025-01-31 15:00 CET.

Attachments

Change in number of shares and votes in Alligator Bioscience

Talk to a Data Expert

Have a question? We'll get back to you promptly.